FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012142457> ?p ?o ?g. }

• W2012142457 endingPage "709" @default.
• W2012142457 startingPage "707" @default.
• W2012142457 abstract "To the Editor: As part of a cohort study of 83 patients with severe acute respiratory syndrome (SARS) in Beijing, China, we conducted a follow-up study of all the patients by routine medical examination. During the process, 3 patients with chest radiographs consistent with active disease were identified as having pulmonary tuberculosis (TB). Here we describe the 1-year clinical outcome and immune response in these patients.Demographic details and coexisting conditions are shown in the Table. Patient 1 was a healthcare worker who became infected with SARS-associated coronavirus (CoV) while on duty with SARS patients. After he was transferred to a hospital dedicated to SARS management, pulmonary TB was diagnosed (positive acid-fast bacilli smear on sputum samples). Patients 2 and 3 were known to have cases of pulmonary TB and became infected with SARS-CoV after contact with other patients hospitalized for SARS. These 2 patients were sputum smear–negative for acid-fast bacilli, and diagnosis was made on the basis of previous exposure to TB, relevant symptoms of typical pulmonary TB, chest radiographs consistent with active disease, a positive tuberculin skin test result, and the finding of cavity regression on chest radiographs after anti-TB treatment was initiated. No cultures were obtained for isolation and comparison of Mycobacterium tuberculosis strains (1). All 3 patients had confirmed SARS based on amplification of SARS-CoV RNA by reverse transcriptase–polymerase chain reaction (RT-PCR) from sputum and stool specimens (2). Patients 2 and 3 recovered without complications; patient 1 had the most severe disease and required mechanical ventilation in an intensive care unit before recovering.TableDemographic and clinical information on severe acute respiratory syndrome (SARS) patients with pulmonary tuberculosis (TB), Beijing, China, 2003Both cellular and humoral immunity were evaluated during the follow-up of these patients. T-lymphocyte subsets were measured 6 months after disease onset by flow cytometry using fluorescein isothiocyanate–labeled specific monoclonal antibodies. Compared to other SARS patients (n = 47), the 3 patients with TB had lower mean CD4+ T cells (368.4/μL vs. 656.6/μL, respectively; p = 0.05) and lower mean CD8+ T cells (371.0/μL vs. 490.1/μL, respectively; p = 0.39). SARS-CoV immunoglobulin G (IgG) antibody titers were measured by enzyme-linked immunosorbent assay kit (Huada Company, Beijing, China) at months 1, 2, 3, 4, 7, 10, and 16 after disease onset. (Titers were not measured for the 3 TB patients at month l.) Compared to most (26 [78.8%] of 33) other SARS patients whose antibodies remained detectable throughout follow-up, 2 of the 3 TB patients (patients 1 and 3) had undetectable antibody titers as of months 7 and 16, respectively. In patient 1, antibody titers, when detectable, were unusually low (40). Both patients 1 and 3 had prolonged viral excretion in stools, sputum, or both. While the median (range) duration of virus excretion in stools and sputa for the entire measurable cohort (n = 56) was 27 (16–127) and 21 (14–52) days, respectively (3), it was 125 and 16 days for patient 1, and 109 and 52 days for patient 3 (viral excretion data could not be obtained from patient 2 because sequential specimens for detection were unavailable).TB in SARS patients has been reported on rare occasions (4,5). In a cohort of 236 patients in Singapore, it was diagnosed in 2 patients after recovery from SARS (4). As with patient 1 in this study, TB had developed after the patient acquired SARS, most likely as the result of reactivation of past infection or new infection with M. tuberculosis, while temporarily immunosuppressed because of SARS (6) and corticoid therapy. Such phenomena have been described with other viral infections such as measles and HIV (7,8). By contrast, patients 2 and 3 were known TB patients who acquired SARS through exposure to SARS patients in the same hospital wards. Both diseases are known to be transiently immunosuppressive (6,9), and their combined effect resulted in more pronounced CD4+ cell decreases in coinfected SARS patients than others. Such immunosuppression also resulted in poorer IgG antibody response in coinfected SARS patients than in others and delayed viral clearance, as shown by longer viral excretion in sputum and stools. While viral excretion could be prolonged in coinfected patients, no virus could be isolated from any RT-PCR–positive specimen collected after 6 weeks of illness, which suggests that excreted viruses were no longer infectious (3).These case reports remind us of the importance of strict isolation of SARS patients, careful use of steroids for their case management, and the possibility of coinfection with TB in SARS patients with incomplete recovery." @default.
• W2012142457 created "2016-06-24" @default.
• W2012142457 creator A5019886822 @default.
• W2012142457 creator A5025337957 @default.
• W2012142457 creator A5026988751 @default.
• W2012142457 creator A5055055641 @default.
• W2012142457 creator A5065043823 @default.
• W2012142457 creator A5071037763 @default.
• W2012142457 creator A5083823901 @default.
• W2012142457 creator A5091813933 @default.
• W2012142457 date "2006-04-01" @default.
• W2012142457 modified "2023-10-18" @default.
• W2012142457 title "Pulmonary Tuberculosis and SARS, China" @default.
• W2012142457 cites W2028730399 @default.
• W2012142457 cites W2074766251 @default.
• W2012142457 cites W2129203060 @default.
• W2012142457 cites W2154957885 @default.
• W2012142457 cites W2315806009 @default.
• W2012142457 cites W4205913980 @default.
• W2012142457 cites W4211104832 @default.
• W2012142457 cites W4298750902 @default.
• W2012142457 doi "https://doi.org/10.3201/eid1204.050264" @default.
• W2012142457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3294680" @default.
• W2012142457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16715587" @default.
• W2012142457 hasPublicationYear "2006" @default.
• W2012142457 type Work @default.
• W2012142457 sameAs 2012142457 @default.
• W2012142457 citedByCount "21" @default.
• W2012142457 countsByYear W20121424572012 @default.
• W2012142457 countsByYear W20121424572017 @default.
• W2012142457 countsByYear W20121424572020 @default.
• W2012142457 countsByYear W20121424572021 @default.
• W2012142457 countsByYear W20121424572022 @default.
• W2012142457 countsByYear W20121424572023 @default.
• W2012142457 crossrefType "journal-article" @default.
• W2012142457 hasAuthorship W2012142457A5019886822 @default.
• W2012142457 hasAuthorship W2012142457A5025337957 @default.
• W2012142457 hasAuthorship W2012142457A5026988751 @default.
• W2012142457 hasAuthorship W2012142457A5055055641 @default.
• W2012142457 hasAuthorship W2012142457A5065043823 @default.
• W2012142457 hasAuthorship W2012142457A5071037763 @default.
• W2012142457 hasAuthorship W2012142457A5083823901 @default.
• W2012142457 hasAuthorship W2012142457A5091813933 @default.
• W2012142457 hasBestOaLocation W20121424571 @default.
• W2012142457 hasConcept C116675565 @default.
• W2012142457 hasConcept C142724271 @default.
• W2012142457 hasConcept C159047783 @default.
• W2012142457 hasConcept C166957645 @default.
• W2012142457 hasConcept C191935318 @default.
• W2012142457 hasConcept C205649164 @default.
• W2012142457 hasConcept C2778137277 @default.
• W2012142457 hasConcept C2779134260 @default.
• W2012142457 hasConcept C2781069245 @default.
• W2012142457 hasConcept C3006700255 @default.
• W2012142457 hasConcept C3007834351 @default.
• W2012142457 hasConcept C3008058167 @default.
• W2012142457 hasConcept C3020799909 @default.
• W2012142457 hasConcept C524204448 @default.
• W2012142457 hasConcept C71924100 @default.
• W2012142457 hasConceptScore W2012142457C116675565 @default.
• W2012142457 hasConceptScore W2012142457C142724271 @default.
• W2012142457 hasConceptScore W2012142457C159047783 @default.
• W2012142457 hasConceptScore W2012142457C166957645 @default.
• W2012142457 hasConceptScore W2012142457C191935318 @default.
• W2012142457 hasConceptScore W2012142457C205649164 @default.
• W2012142457 hasConceptScore W2012142457C2778137277 @default.
• W2012142457 hasConceptScore W2012142457C2779134260 @default.
• W2012142457 hasConceptScore W2012142457C2781069245 @default.
• W2012142457 hasConceptScore W2012142457C3006700255 @default.
• W2012142457 hasConceptScore W2012142457C3007834351 @default.
• W2012142457 hasConceptScore W2012142457C3008058167 @default.
• W2012142457 hasConceptScore W2012142457C3020799909 @default.
• W2012142457 hasConceptScore W2012142457C524204448 @default.
• W2012142457 hasConceptScore W2012142457C71924100 @default.
• W2012142457 hasIssue "4" @default.
• W2012142457 hasLocation W20121424571 @default.
• W2012142457 hasLocation W20121424572 @default.
• W2012142457 hasLocation W20121424573 @default.
• W2012142457 hasLocation W20121424574 @default.
• W2012142457 hasOpenAccess W2012142457 @default.
• W2012142457 hasPrimaryLocation W20121424571 @default.
• W2012142457 hasRelatedWork W3020699490 @default.
• W2012142457 hasRelatedWork W3041264183 @default.
• W2012142457 hasRelatedWork W3043486364 @default.
• W2012142457 hasRelatedWork W3087090141 @default.
• W2012142457 hasRelatedWork W3087967611 @default.
• W2012142457 hasRelatedWork W3178186717 @default.
• W2012142457 hasRelatedWork W3184386184 @default.
• W2012142457 hasRelatedWork W4287374796 @default.
• W2012142457 hasRelatedWork W4290085574 @default.
• W2012142457 hasRelatedWork W3127156785 @default.
• W2012142457 hasVolume "12" @default.
• W2012142457 isParatext "false" @default.
• W2012142457 isRetracted "false" @default.
• W2012142457 magId "2012142457" @default.
• W2012142457 workType "article" @default.